Prevention by Antidepressant Drugs of Reserpine Effect on Pyridine Nucleotide Metabolism

A variety of structurally unrelated antidepressant drugs, including both monoamine oxidase (MAO)-inhibitors and non-MAO-inhibitors, prevent the effect of reserpine on the nicotinamide-induced increase in NAD. A single injection of imipramine or iproniazid was effective when given at any time up to s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular pharmacology 1966-07, Vol.2 (4), p.347-351
Hauptverfasser:	QUINN, GERTRUDE P., GREENGARD, PAUL, REID, MARIA B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aminopyrine - pharmacology Amitriptyline - pharmacology Amphetamine - pharmacology Animals Antidepressive Agents - pharmacology Atropine - pharmacology Benactyzine - pharmacology Caffeine - pharmacology Chlorpheniramine - pharmacology Chlorpromazine - pharmacology Female Hexobarbital - pharmacology Hydralazine - pharmacology Hypothalamus - drug effects Imipramine - pharmacology Iproniazid - pharmacology Isoniazid - pharmacology Liver - metabolism Meprobamate - pharmacology Methacholine Compounds - pharmacology Morphine - pharmacology NAD - pharmacology Niacinamide - pharmacology Pargyline - pharmacology Pentobarbital - pharmacology Phenylbutazone - pharmacology Phenytoin - pharmacology Quinacrine - pharmacology Rats Reserpine - pharmacology Tranylcypromine - pharmacology Tripelennamine - pharmacology Zoxazolamine - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!